There’s no point managing stock you can’t see…
The question of “what stock do we actually have?” is harder to answer than it should be across pathology networks. The data exists, but it’s spread disparately across systems, sites and spreadsheets.
Oftentimes, teams don’t even have sight on whether goods have even been received, so visibility is hard to track and retrieve. By the time it is retrieved, it is already out of date.
Stock being out of date sounds a little inconveniencing, but the impacts are greater than frustration. Out of date stock and data is non-compliant, which puts your organisation at risk of scrutiny. Equally, when your system says something is there and it isn’t, you have to investigate stock diversions and place last minute orders to make ends meet.
This lack of visibility and accuracy impacts your ability to provide care, but there’s another knock-on effect. Further than stock availability, financial oversight becomes a lot harder. If your teams are over-ordering to hedge against uncertainty, your expenditures are set to go up – all due to a lack of clarity and control.
For a stock management platform to be useful, it needs to offer real-time visibility, centralising your data across departments for an accurate read on what’s going on in your network. That’s why we created CentrixConnect Stock Management.
CentrixConnect Stock Management provides a real-time view of both stock quantity and financial value at any point in time. Our platform supports directorate reporting and allows leaders to understand what’s held, where it is and what it is costing, without manual reconciliation.
Our platform also helps address over-ordering before it becomes a problem. Ordering behaviour is learned over time, enabling detection of unusual patterns. Live warnings can be presented at the point of order, helping teams pause and correct issues early rather than dealing with over-stocking later down the line.
For governance and compliance support, our retrospective anomaly reporting provides an additional layer of control. Instead of relying on occasional reviews or manual spot checks, teams have structured insight into what has happened and where attention is needed.
With this level of visibility, we’re changing how pathology networks operate. Decisions are based on current data rather than assumptions. Financial conversations are grounded in evidence. Stock is ordered because it is needed, not because confidence is low.
Real-time visibility isn’t about micromanagement. It’s about replacing uncertainty with clarity so your teams can work with confidence.
If better stock and financial visibility would make a difference in your network, speak to us at hello@centrixconnect.com